Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.

Also called NCT01062516

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Ruttonjee Hospital (from the registry)
Registry
  • NCT NCT01062516
Other papers using this trial's data
  • Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial American heart journal, 2011-11 DOI, PubMed 22093203

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01062516. Randomized; quadruple masking; primary purpose diagnostic. Start 2010-01 (registry gives no type); primary completion 2010-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
Condition
Acute Coronary Syndrome
Condition
Acute Myocardial Infarction
Intervention (Drug)
esomeprazole 20 mg daily
Intervention (Drug)
famotidine 40 mg daily
Lead sponsor
Ruttonjee Hospital (class: other)

Record details

Record id
cardio:ct-nct01062516
Content hash
125b1d87858303dd7ad8954c97ccf874e3f53face54f77717158598e3492b3c7